These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17107276)

  • 1. Discontinued drugs in 2005: pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs.
    Lee KK
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1497-505. PubMed ID: 17107276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinued drugs in 2006: pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs.
    Ozdemir C; Akdis CA
    Expert Opin Investig Drugs; 2007 Sep; 16(9):1327-44. PubMed ID: 17714020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinued drugs 2011: pulmonary, allergy, gastrointestinal and arthritis.
    Antoniu SA
    Expert Opin Investig Drugs; 2012 Nov; 21(11):1607-18. PubMed ID: 22839355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinued drugs, 2007: pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs.
    Antoniu SA
    Expert Opin Investig Drugs; 2008 Nov; 17(11):1651-61. PubMed ID: 18922102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinued drugs for pulmonary, allergy, gastrointestinal, arthritis (2012).
    Antoniu SA
    Expert Opin Investig Drugs; 2013 Nov; 22(11):1453-64. PubMed ID: 24024675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinued drugs 2008: pulmonary and allergy.
    Antoniu SA
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1799-805. PubMed ID: 19852567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinued drugs 2010: rheumatology, allergy and dermatology, pulmonary.
    Antoniu SA
    Expert Opin Investig Drugs; 2011 Sep; 20(9):1175-87. PubMed ID: 21793791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinued drugs in 2011: cardiovascular drugs.
    Zhao HP; Jiang HM; Xiang BR
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1449-62. PubMed ID: 22827213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinued dermatological drugs in 2014.
    Phuong C; Maibach HI
    Expert Opin Investig Drugs; 2015; 24(11):1483-91. PubMed ID: 26414692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinued drugs in 2006: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2008 Mar; 17(3):269-83. PubMed ID: 18321227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinued drugs in 2008: cardiovascular drugs.
    Zhang XS; Xiang BR
    Expert Opin Investig Drugs; 2009 Jul; 18(7):875-85. PubMed ID: 19548849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinued drugs in 2006: cardiovascular drugs translational medicine perspective.
    Feuerstein GZ; Ruffolo RR
    Expert Opin Investig Drugs; 2007 Sep; 16(9):1315-26. PubMed ID: 17714019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of the pharmaceutical industry and drug development in dermatology and dermatologic health care.
    Altman DJ
    Dermatol Clin; 2000 Apr; 18(2):287-96. PubMed ID: 10791155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinued drugs in 2005: cardiovascular drugs.
    Suckling K
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1299-308. PubMed ID: 17040192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Genentech Novartis stifled a promising drug: biotech firm tried to pursue a peanut allergy inject, but contract got in way; Zach avoids a "kiss of death".
    Hamilton DP
    Wall St J (East Ed); 2005 Apr; ():A1, A10. PubMed ID: 15926244
    [No Abstract]   [Full Text] [Related]  

  • 16. Discontinued drugs in 2008: oncology drugs.
    Williams R
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1581-94. PubMed ID: 19663760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs with breakthrough status charm investors.
    Senior M
    Nat Biotechnol; 2013 Nov; 31(11):945-7. PubMed ID: 24213748
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug pipeline: 3Q15.
    DeFrancesco L
    Nat Biotechnol; 2015 Nov; 33(11):1126. PubMed ID: 26544135
    [No Abstract]   [Full Text] [Related]  

  • 19. Off-label uses and side effects of infliximab.
    Scheinfeld N
    J Drugs Dermatol; 2004; 3(3):273-84. PubMed ID: 15176162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the pharmaceutical industry in drug development in dermatology.
    Cauwenbergh G
    Clin Dermatol; 2002; 20(5):467-73. PubMed ID: 12435516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.